151 related articles for article (PubMed ID: 3309817)
1. [Effects of beta-lactamases on the antibacterial activity of carumonam and aztreonam against Klebsiella sp. in comparison with 4 other beta-lactams].
Labia R; Morand A; Pitton JS; Philippin JL; Fournier P
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):796-9. PubMed ID: 3309817
[TBL] [Abstract][Full Text] [Related]
2. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases.
Raimondi A; Mattina R; Cocuzza CE
Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365
[TBL] [Abstract][Full Text] [Related]
3. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
[TBL] [Abstract][Full Text] [Related]
4. [Comparative activities of 15 beta-lactam antibiotics against 590 strains of Klebsiella pneumoniae according to the production of beta-lactamase].
Bercion R; Meyran M; Labia R; Thabaut A
Pathol Biol (Paris); 1991 May; 39(5):353-60. PubMed ID: 1881669
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of cefotetan and Sch 34343 to beta-lactamases produced by strains of Bacteroides that hydrolyse cefoxitin or imipenem.
Andrew JH; Greenwood D
J Antimicrob Chemother; 1987 May; 19(5):591-5. PubMed ID: 3497146
[TBL] [Abstract][Full Text] [Related]
6. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
Shi WF; Zhou J; Qin JP
Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
Zarakolu P; Metan G; Hasçelik G; Akova M
Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
[TBL] [Abstract][Full Text] [Related]
8. Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
Padilla E; Alonso D; Doménech-Sánchez A; Gomez C; Pérez JL; Albertí S; Borrell N
Antimicrob Agents Chemother; 2006 Jun; 50(6):2258-60. PubMed ID: 16723600
[TBL] [Abstract][Full Text] [Related]
9. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
10. [Sanfetrinem, the member of trinems--in vitro activity against Klebsiella pneumoniae producing ESBL].
Wieczorek P; Sacha PT; Leszczyńska K; Jakoniuk P; Zalewska M
Med Dosw Mikrobiol; 2006; 58(1):27-32. PubMed ID: 16871970
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic.
Imada A; Kondo M; Okonogi K; Yukishige K; Kuno M
Antimicrob Agents Chemother; 1985 May; 27(5):821-7. PubMed ID: 3874598
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporin.
Chin NX; Neu HC
Chemioterapia; 1986 Apr; 5(2):92-100. PubMed ID: 3518967
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
Wang FD; Lin ML; Lee WS; Liu CY
Int J Antimicrob Agents; 2004 Jun; 23(6):590-5. PubMed ID: 15194130
[TBL] [Abstract][Full Text] [Related]
14. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
Nijssen S; Florijn A; Bonten MJ; Schmitz FJ; Verhoef J; Fluit AC
Int J Antimicrob Agents; 2004 Dec; 24(6):585-91. PubMed ID: 15555882
[TBL] [Abstract][Full Text] [Related]
15. Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates.
Giakkoupi P; Tzouvelekis LS; Daikos GL; Miriagou V; Petrikkos G; Legakis NJ; Vatopoulos AC
J Clin Microbiol; 2005 Jan; 43(1):494-6. PubMed ID: 15635025
[TBL] [Abstract][Full Text] [Related]
16. [Transfer of resistance to 3rd generation cephalosporins and aztreonam in strains of Klebsiella pneumoniae producing extended spectrum beta-lactamases].
Babálová M; Blahová J; Králiková K; Krcméry V; Hanzen J; Balogová O; Milosovic P
Epidemiol Mikrobiol Imunol; 1999 Feb; 48(1):21-7. PubMed ID: 11038673
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of ertapenem against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated in Spain.
Hernández JR; Velasco C; Romero L; Martínez-Martínez L; Pascual A
Int J Antimicrob Agents; 2006 Nov; 28(5):457-9. PubMed ID: 17008066
[TBL] [Abstract][Full Text] [Related]
18. The in-vitro activity and beta-lactamase stability of carumonam.
Neu HC; Chin NX; Labthavikul P
J Antimicrob Chemother; 1986 Jul; 18(1):35-44. PubMed ID: 3531143
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Klebsiella oxytoca septicaemia isolates resistant to aztreonam and cefuroxime.
Wu SW; Dornbusch K; Göransson E; Ransjö U; Kronvall G
J Antimicrob Chemother; 1991 Sep; 28(3):389-97. PubMed ID: 1960120
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli.
Bujdáková H; Kallová J; Lausová A; Kettner M
Microbios; 1995; 84(339):87-90. PubMed ID: 8628124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]